- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07376863
Impact of Structured Exercise Programs on Cognitive, Motor and Behavioral Outcomes in Children With ADHD (ADHD)
Effects of Gince Zumba and Square Stepping Exercises on Motor and Cognitive Functions in Children With Attention-Deficit/Hyperactivity Disorder
The purpose of this study is to investigate the effects of structured exercise interventions (Gince Zumba and Square Stepping) on cognitive, motor and behavioral functions of children diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). Specifically, this study aims to:
- compare the effects of Gince Zumba and Square Stepping on motor perfoemance, including coordination and reaction time.
- examine changes in cognitive functions, particularly attention and memory functions following each exercise intervention.
- evaluate the impact of both exercise programs on behavioral symptoms and social adaptation as reported by parents
- determine whether rhytm-based exercise (Gince Zumba) or cognitively demanding stepping exercise (Square Stepping) is more effective in imroving functional outcomes in children with ADHD.
Based on these aims, the study was conducted as follows:
- Eligible participants were randomly assigned to one of the three intervention groups ( square stepping group, gince zumba group, control group)
- All participants underwent baseline assessments prior to the interventions
- Participants in the intervention groups performed assigned activities for eight weeks, while the control group did not engage in regular physical activity during the same period.
- Following the completion of the interventions, all participants underwent post-intervention assessments
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Adana, Turkey (Türkiye), 01170
- Cukurova University, Faculty of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Ability to read and understand Turkish language
- Use of psychostimulant medication for at least 2 months prior to enrollment
Exclusion Criteria:
- Diagnosis of intellectual disability
- Comorbidity of medical or psychiatric
- Inability to participate in physical activity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Gince Zumba Group
Participants in this arm received the Gince Zumba exercise program conducted two times per week for eight weeks
|
The Gince Zumba interventions consisted of rhythm-based aerobic exercises , requiring cognitive engagement through attention, coordination, and sequencing of movements, and aiming to support cognitive functions."
Other Names:
|
|
Experimental: Square Stepping Group
Participants in this arm received the Square Stepping exercise program conducted two times per week for eight weeks
|
The Square Stepping Exercise intervention consisted of step patterns performed on a gridded mat in group sessions,, requiring cognitive engagement through visuospatial processing, attention, working memory, and sequencing of movement patterns, and aiming to support cognitive functions."
|
|
No Intervention: Control Group
Participants in this arm received no regular physical activity for eight weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stroop Color Test Completion Time
Time Frame: Baseline and at the end of the 8-week intervention
|
The Stroop Color Test is a neuropsychological assessment used to evaluate selective attention, cognitive flexibility, and inhibitory control. In this study, the primary outcome is the total time required to complete the interference condition of the Stroop task, measured in seconds. Shorter completion time indicates better attentional control and executive functioning. Measurements will be obtained before and after the 8-week exercise intervention. |
Baseline and at the end of the 8-week intervention
|
|
Visual-Auditory Digit Span Test Total Score
Time Frame: Baseline and after 8 weeks
|
The Visual-Auditory Digit Span Test (VADST) is a neuropsychological assessment used to evaluate short-term memory and working memory through auditory and visual digit recall tasks. The primary outcome measure is the total test score, expressed in points, obtained from correct responses across all subtests. Higher total scores indicate better memory performance and cognitive processing capacity. The assessment will be administered at baseline and after the 8-week intervention period. |
Baseline and after 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blaze Pod Reaction Time Score
Time Frame: Baseline and after 8 weeks
|
The BlazePod system is a light-based interactive training and assessment tool used to evaluate visuomotor performance. The secondary outcome measure is the mean reaction time, recorded in milliseconds, representing the time elapsed between the visual stimulus and the participant's motor response. Shorter reaction time indicates faster visuomotor processing and motor response speed. Reaction time data will be collected digitally via the BlazePod mobile application. The assessment will be conducted at baseline and after the 8-week intervention period. |
Baseline and after 8 weeks
|
|
Blaze Pod Number of Hits
Time Frame: Baseline and after 8 weeks
|
The BlazePod system is a light-based interactive assessment tool used to evaluate visuomotor performance and response accuracy. The secondary outcome measure is the total number of correct responses (hits) recorded during the task. Hits represent the number of targets successfully activated within the predefined assessment duration. Higher hit counts indicate better visuomotor coordination and task performance. Performance data will be recorded digitally via the BlazePod mobile application. The assessment will be conducted at baseline and after the 8-week intervention period. |
Baseline and after 8 weeks
|
|
Blaze Pod Total Number of Errors
Time Frame: Baseline and after 8 weeks
|
The BlazePod system is a light-based interactive assessment tool used to evaluate visuomotor performance during goal-directed motor tasks. The secondary outcome measure is the total error score, calculated as the sum of missed targets (miss hits) and incorrect responses (strikes) recorded during the assessment. The total error score is expressed as a numerical count. Lower error scores indicate better response accuracy and motor control. All performance data will be recorded digitally via the BlazePod mobile application. The assessment will be conducted at baseline and after the 8-week intervention period. |
Baseline and after 8 weeks
|
|
Conners Parent Rating Scale Total Score
Time Frame: Baseline and after 8 weeks
|
The Conners Parent Rating Scale (CPRS) is a standardized questionnaire used to assess behavioral symptoms associated with attention-deficit/hyperactivity disorder (ADHD) in children, as reported by parents. The secondary outcome measure is the total score obtained from the scale, expressed in points based on parent responses to Likert-type items. Higher total scores indicate greater severity of ADHD-related behavioral symptoms. The assessment will be completed by parents at baseline and after the 8-week intervention period. |
Baseline and after 8 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Gonca İnce, Prof., Çukurova University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 127/64
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit Hyperactivity Disorder (ADHD)
-
Çağlar Charles Daniel JaicksCompletedADHD | Attention Deficit Hyperactivity Disorder (ADHD)Turkey (Türkiye)
-
EMOTIVCompletedADHD | ADHD - Combined Type | ADHD - Attention Deficit Disorder With HyperactivitySouth Korea
-
Seattle Children's HospitalRecruitingADHD | ADHD - Attention Deficit Disorder With HyperactivityUnited States
-
Children's National Research InstituteRecruitingADHD | Attention Deficit Hyperactivity Disorder | Attention-Deficit Hyperactivity Disorder | Attention Deficit Disorder | ADD | ADHD Predominantly Inattentive Type | ADHD - Combined Type | ADHD, Predominantly Hyperactive - Impulsive | Attention-Deficit Disorder in Adolescence | Attention-Deficit Hyperactivity...United States
-
I-Ching ChouBened Biomedical Co., Ltd.Enrolling by invitationADD/ADHD | ADHD - Attention Deficit Disorder With HyperactivityTaiwan
-
Cingulate TherapeuticsPremier Research Group plcCompletedADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Cingulate TherapeuticsSuspendedPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Otsuka Pharmaceutical Co., Ltd.RecruitingAttention-Deficit Hyperactivity Disorder(ADHD)Japan
-
Universidade do Sul de Santa CatarinaAssociação Brasileira de Cannabis MedicinalRecruitingAttention-Deficit/Hyperactivity Disorder (ADHD)Brazil
-
Children's Hospital Medical Center, CincinnatiPatient-Centered Outcomes Research Institute; Children's Hospital of Philadelphia and other collaboratorsNot yet recruitingAttention-Deficit/Hyperactivity Disorder (ADHD)United States
Clinical Trials on Gince Zumba Exercise
-
Mayo ClinicAlzheimer's AssociationCompletedCognitive ImpairmentUnited States
-
Rashid Latif Medical CollegeCompletedPoly Cystic Ovary SyndromePakistan
-
Manuel Jesús Rodríguez ChavarríaCompletedDepression | Anxiety | Psychological Well-beingSpain
-
Ege UniversityCompletedAdiposity | Physical FitnessTurkey (Türkiye)
-
Dr. Soetomo General HospitalUniversitas AirlanggaCompleted
-
Dr. Ebru CEVİZCompletedBody Composition | Muscle Strength | Balance | Healthy Volunteers - Male and FemaleTurkey
-
Gümüşhane UniversıtyCompletedQuality of Life | Aerobic Exercise | Psychological Resilience | Zumba ExerciseTurkey (Türkiye)
-
The Hong Kong Polytechnic UniversityActive, not recruitingMild Cognitive ImpairmentPhilippines